The integration of artificial intelligence and machine learning in diabetes care is transforming disease management through predictive analytics and automated decision-making. Machine learning algorithms analyze vast datasets to identify early signs of diabetes, optimize insulin dosing, and personalize treatment strategies. AI-driven digital platforms enhance real-time glucose monitoring, allowing for proactive intervention in glycemic fluctuations. Advanced neural networks are being utilized to detect complications such as diabetic retinopathy with high precision. Automated insulin delivery systems, guided by AI, improve time-in-range outcomes, reducing the risk of hypoglycemia. As technology continues to evolve, AI-powered tools are set to enhance patient engagement, streamline clinical workflows, and refine therapeutic interventions for more effective diabetes care.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States